OTCMKTS:RGINRegenicin Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Regenicin Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $0.01 0.00 (0.00 %) (As of 07/3/2020 04:00 PM ET) Add Compare Share Today's Range$0.01Now: $0.01▼$0.0150-Day Range$0.01MA: $0.01▼$0.0252-Week Range$0.01Now: $0.01▼$0.04Volume10,400 shsAverage Volume55,989 shsMarket Capitalization$1.81 millionP/E RatioN/ADividend YieldN/ABeta0.67 ProfileAdvanced ChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsSocial Media Regenicin, Inc. focuses on developing and commercializing a technology of tissue-engineered skin substitutes. The company's products are used to restore the qualities of healthy human skin for use in the treatment of burns, chronic wounds, and various plastic surgery procedures. Its development products include NovaDerm, a cultured skin substitute product for the treatment of burns; and TempaDerm to treat smaller wound areas on patients, such as ulcers. The company was formerly known as Windstar, Inc. and changed its name to Regenicin, Inc. in July 2010. Regenicin, Inc. was founded in 2007 and is based in Little Falls, New Jersey.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Regenicin. Previous Next 2.7 Community Rank Outperform VotesRegenicin has received 81 “outperform” votes. (Add your “outperform” vote.)Underperform VotesRegenicin has received 71 “underperform” votes. (Add your “underperform” vote.)Community SentimentRegenicin has received 53.29% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Regenicin and other stocks. Vote “Outperform” if you believe RGIN will outperform the S&P 500 over the long term. Vote “Underperform” if you believe RGIN will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldRegenicin does not currently pay a dividend.Dividend GrowthRegenicin does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Regenicin insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 0.0Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.54 out of 5 stars Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:RGIN Previous Symbol CUSIPN/A CIK1412659 Webwww.regenicin.com Phone973-557-8914Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value($0.02) per share Price / Book-0.59Profitability EPS (Most Recent Fiscal Year)N/A Net Income$-760,000.00 Net MarginsN/A Return on EquityN/A Return on Assets-9,070.69%Miscellaneous Employees3 Outstanding Shares153,770,000Market Cap$1.81 million Next Earnings DateN/A OptionableNot Optionable OTC:RGIN Rates by TradingView Receive RGIN News and Ratings via Email Sign-up to receive the latest news and ratings for RGIN and its competitors with MarketBeat's FREE daily newsletter. Regenicin (OTCMKTS:RGIN) Frequently Asked Questions How has Regenicin's stock been impacted by COVID-19 (Coronavirus)? Regenicin's stock was trading at $0.0185 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, RGIN stock has decreased by 36.2% and is now trading at $0.0118. View which stocks have been most impacted by Coronavirus. Has Regenicin been receiving favorable news coverage? Media stories about RGIN stock have been trending negative this week, according to InfoTrie Sentiment. InfoTrie ranks the sentiment of media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Regenicin earned a media sentiment score of -2.4 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the stock's share price in the next several days. View the latest news about Regenicin. Who are some of Regenicin's key competitors? Some companies that are related to Regenicin include Invivo Therapeutics (NVIV), RA Medical Systems (RMED), Obalon Therapeutics (OBLN), Cytocore (MDIT), Neurometrix (NURO), Calmare Therapeutics (CTTC), AdvanSource Biomaterials Corpration (ASNB), TearLab (TEAR), Nuvectra (NVTRQ), Valeritas (VLRXQ), Lombard Medical (EVARF), Oncologix Tech (OCLG), Prourocare Medical (PUMD), Quantrx Biomedical (QTXB) and Revolutions Medical (RMCP). View all competitors. What other stocks do shareholders of Regenicin own? Based on aggregate information from My MarketBeat watchlists, some companies that other Regenicin investors own include Amarantus Bioscience (AMBS), Energous (WATT), Vital Therapies (VTL), Xerox (XRX), Allergan (AGN), Leafbuyer Technologies (LBUY), Cheniere Energy (LNG), Horsehead (ZINCQ), Ambarella (AMBA) and Alstom (ALO). Who are Regenicin's key executives? Regenicin's management team includes the following people: Mr. Randall McCoy, Chairman, CEO & Pres (Age 70)Mr. John J. Weber, CFO & Director (Age 69)Dr. J. Roy Nelson, Chief Science Officer (Age 71) What is Regenicin's stock symbol? Regenicin trades on the OTCMKTS under the ticker symbol "RGIN." How do I buy shares of Regenicin? Shares of RGIN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Regenicin's stock price today? One share of RGIN stock can currently be purchased for approximately $0.01. How big of a company is Regenicin? Regenicin has a market capitalization of $1.81 million. Regenicin employs 3 workers across the globe. What is Regenicin's official website? The official website for Regenicin is www.regenicin.com. How can I contact Regenicin? Regenicin's mailing address is 10 HIGH COURT, LITTLE FALLS NJ, 07424. The company can be reached via phone at 973-557-8914. This page was last updated on 7/5/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
